Skip to main content

Table 2 List of measures and data collection schedule

From: The Breathe Easier through Weight Loss Lifestyle (BE WELL) Intervention: A randomized controlled trial

 

Baseline

Follow-up month

  

6

12

Questionnaires

Juniper Asthma Control Questionnaire (ACQ)

X

X

X

Juniper Mini Asthma-specific Quality of Life Questionnaire (mini-AQLQ)

X

X

X

Two-week asthma symptom diary

X

X

X

Baseline Dyspnea Index

X

  

Transition Dyspnea Index

 

X

X

Three-day food record

X

X

X

Eating Habits Confidence Survey

X

X

X

Social Support and Eating Habits Survey

X

X

X

Stanford Seven-day Physical Activity Recall

X

X

X

Exercise Confidence Survey

X

X

X

Total number of steps in the past seven days (per pedometer reading)

X

X

X

Social Support and Exercise Survey

X

X

X

Rose questionnaire for angina and peripheral vascular disease

X

X

X

Center for Epidemiologic Studies Depression Scale (CES-D)

X

X

X

Depression Anxiety Stress Scale

X

X

X

Obesity Related Problems Scale

X

X

X

12-item Short Form Health Survey (SF-12)

X

X

X

Berlin Questionnaire for Sleep Apnea

X

X

X

Gastroesophageal Reflux Disease Symptom Assessment Scale

X

X

X

Adverse events

X

X

X

Care at non-Kaiser health care facilities

X

X

X

Demographics

X

  

Clinical Measures

Height

X

  

Weight, waist circumference, hip circumference, waist to hip ratio (WHR)

X

X

X

Blood pressure

X

X

X

Spirometry: Forced maneuver - FEV1, FEV6, FVC (absolute and % predicted values), FEV1/FVC, FEV1/FEV6; Slow maneuver - VT, ERV, IC, VCin, VCex

X

X

X

Data from KPNC Electronic Databases

Current medical problems

X

 

X

Medications currently prescribed

X

X

X

Medications dispensed2

X

 

X

Health care utilization2

X

 

X

Primary care provider characteristics

X

 

X

Recruitment and intervention process measures (monitored continuously)

Safety of participants in the intervention arm (monitored continuously)

  1. 1Pre- and post-bronchodilator spirometry will be obtained at baseline visit 1 to determine reversibility of airway obstruction, which is an eligibility criterion. Only pre-bronchodilator spirometry will be performed at baseline visit 2 and at 6- and 12-month assessments and the measurements obtained will be used for analysis.
  2. 2Data will be extracted for a period of 12 months before and after randomization.
  3. Abbreviations: ERV, expiratory reserve volume; FEV1, forced expiratory volume in one second; FEV6, forced expiratory volume in six seconds; FVC, forced vital capacity; IC, inspiratory capacity; KPNC, Kaiser Permanente in Northern California; VCin and VCex, inspiratory and expiratory vital capacity; VT, tidal volume.
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us